Vinay Prasad, a top official at the Food and Drug Administration, has suddenly departed after a series of controversial ...

Novo Nordisk (NYSE:NVO) announced on Tuesday that Maziar Mike Doustdar will become its new president and chief executive ...

Aclaris Therapeutics, Inc. (NASDAQ: ACRS) announced the appointment of Roland Kolbeck, Ph.D., as its new Chief Scientific ...

Illinois Gov. JB Pritzker and former U.S. Commerce Secretary Penny Pritzker are at the center of an effort to drive more ...

In India, Zaynich will be positioned as a third-line treatment, primarily for ICU patients when other antibiotics have failed ...

Novo Nordisk today announced that Maziar Mike Doustdar has been appointed as president and chief executive officer, effective ...

Professor Robin May will step down as the FSA’s Chief Scientific Adviser in September to become Interim Chief Scientific ...

The FDA has cleared investigational new drug applications for ZW251 and RV‑01, advancing novel treatments for solid tumors in first-in-human trials.

NeuroScientific Biopharmaceuticals has made a second heavy-hitting appointment, with Melbourne-based exec Nathan Smith ...

While chief scientific officer and executive vice president of gaming might be uncommon additions to C-suite, 451 Research analyst Jean Atelsek they're really about artificial intelligence and the ...

Investing.com -- Novo Nordisk (NYSE: NVO) has appointed Maziar Mike Doustdar as its new president and chief executive officer ...